Halozyme Therapeutics, Inc. (HALO)

63.60 +0.52 (+0.82%) USD  |  NASDAQ  |  Apr 07, 16:00
64.40 +0.80 (+1.26%) After-Hours: 20:00
More

Halozyme Therapeutics Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Skye Bioscience, Inc. --
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Stryker Corp. Upgrade
Glaukos Corp. Upgrade